Iseda Keiichi, Ono Shigeki, Onoda Keisuke, Satoh Motoyoshi, Manabe Hiroaki, Nishiguchi Mitsuhisa, Takahashi Kenji, Tokunaga Koji, Sugiu Kenji, Date Isao
Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
J Neurosurg. 2007 Jul;107(1):128-35. doi: 10.3171/JNS-07/07/0128.
Inflammation in the subarachnoid space and apoptosis of arterial endothelial cells have been implicated in the development of delayed cerebral vasospasm after subarachnoid hemorrhage (SAH). The authors investigated mechanisms of possible antivasospastic effects of N-benzyl-oxycarbonyl-Val-Ala-Asp-fluoromethylketone (Z-VAD-FMK), a caspase inhibitor that can inhibit both inflammatory and apoptotic systems, in animal models of SAH.
Rabbits were assigned to three groups of eight animals each and were subjected to SAH by injection of blood into the cisterna magna. The experiments were performed in the following groups: SA only, SAH + vehicle, and SAH + Z-VAD-FMK. The Z-VAD-FMK (1 mg) or vehicle (5% dimethyl sulfoxide) was intrathecally administered before SAH induction. Diameters of the basilar artery (BA) were measured on angiograms obtained before and 2 days after SAH. The BA diameter on Day 2 was expressed as a percentage of that before SAH. Interleukin (IL)-1 in the cerebrospinal fluid (CSF) was examined using Western blotting, and brains were immunohistochemically examined for caspase-1 and IL-1beta. In a separate experiment, 20 rats were subjected to SAH and their brains were immunohistochemically assessed for caspase-1, IL-1beta, and macrophages. RESULTS. In rabbits, Z-VAD-FMK significantly attenuated cerebral vasospasm (the BA diameter on Day 2 in SAH-only, SAH + vehicle, and SAH + Z-VAD-FMK groups was 66.6 +/- 3.2%, 66.3 +/- 3.7%, and 82.6 +/- 4.9% of baseline, respectively), and suppressed IL-1beta release into the CSF and also suppressed immunoreactivities of caspase-1 and IL-1P in macrophages infiltrating into the subarachnoid space. Immunoreactivities for caspase-1 and IL-1P were observed in immunohistochemically proven infiltrating macrophages in rats.
These results indicate that caspase activation may be involved in the development of SAH-induced vasospasm through inflammatory reaction.
蛛网膜下腔出血(SAH)后迟发性脑血管痉挛的发生与蛛网膜下腔炎症及动脉内皮细胞凋亡有关。作者在SAH动物模型中研究了N-苄氧羰基-缬氨酸-丙氨酸-天冬氨酸-氟甲基酮(Z-VAD-FMK)(一种可抑制炎症和凋亡系统的半胱天冬酶抑制剂)可能的抗血管痉挛作用机制。
将兔子分为三组,每组8只,通过向小脑延髓池注射血液诱导SAH。实验在以下几组中进行:仅SAH组、SAH+赋形剂组和SAH+Z-VAD-FMK组。在诱导SAH前鞘内注射Z-VAD-FMK(1mg)或赋形剂(5%二甲基亚砜)。在SAH前和SAH后2天获得的血管造影片上测量基底动脉(BA)直径。第2天的BA直径表示为SAH前直径的百分比。采用蛋白质印迹法检测脑脊液(CSF)中的白细胞介素(IL)-1,并对大脑进行半胱天冬酶-1和IL-1β的免疫组织化学检测。在另一项实验中,20只大鼠接受SAH,对其大脑进行半胱天冬酶-1、IL-1β和巨噬细胞的免疫组织化学评估。结果:在兔子中,Z-VAD-FMK显著减轻了脑血管痉挛(仅SAH组、SAH+赋形剂组和SAH+Z-VAD-FMK组第2天的BA直径分别为基线的66.6±3.2%、66.3±3.7%和82.6±4.9%),抑制了IL-1β释放到CSF中,还抑制了浸润到蛛网膜下腔的巨噬细胞中半胱天冬酶-1和IL-1β的免疫反应性。在大鼠免疫组织化学证实的浸润巨噬细胞中观察到半胱天冬酶-1和IL-1β的免疫反应性。
这些结果表明半胱天冬酶激活可能通过炎症反应参与SAH诱导的血管痉挛的发生。